Comorbidities among COVID-19 patients: based on studies published before 16 February 2020

Added April 25, 2020

Citation: Emami A, Javanmardi F, Pirbonyeh N, et al. Prevalence of underlying diseases in hospitalized patients with COVID-19: A systematic review and meta-analysis. Archives of Academic Emergency Medicine 2020; 8(1): e35

What is this? The presence of certain comorbidities may represent potential risk factors for poorer outcomes for patients with COVID-19.

In this rapid systematic review, the authors searched for articles reporting clinical characteristics or epidemiological information for hospitalized patients with COVID-19. They did not restrict their searches by type or language of publication (but only evaluated the abstracts for articles published in Chinese) and did the search up to 16 February 2020. They identified 10 cross-sectional studies and were able to include data from 3403 patients in their analyses.

What was found: At the time of the review, the available research included by the authors showed that the most prevalent underlying conditions in hospitalized patients with COVID-19 were hypertension (16%), cardiovascular disease (12%), diabetes mellitus (7.9%) and smoking history (7.6%).


Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.